Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...

Novo Nordisk has announced plans to move its ziltivekimab into phase 3 clinical development in atherosclerosis with chronic kidney disease after a mid-stage trial met its main goal.

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

Getting to know what’s going on in your body can help you manage type 2 diabetes well. It’s a chronic condition in which your body doesn’t use insulin properly. This causes sugar to build up ...